光子计数CT与MRI在肾脏肿块定性中诊断性能的前瞻性研究
前瞻性纳入24例成人患者共70个病灶,对比研究型全身光子计数CT(PCCT)与腹部MRI对肾脏肿块的检出与定性。两名阅片者对PCCT与MRI的阅片者间信度及每例肾细胞癌(RCC)敏感度相当;MRI将更多病灶判为主要实性(R1 58/70 vs 52/70,P<0.001)。
要点
- PCCT检出和定性肾脏肿块的阅片者间信度及每例RCC敏感度与MRI相当。
- MRI将更多病灶判为主要实性(R1 58/70 vs 52/70,P<0.001;R2 60/70 vs 55/70,P<0.001)。
- PCCT可经物质分解分析改进病灶内部成分的定性。
核心结论
- 研究型全身PCCT扫描在检出和定性肾脏肿块方面的阅片者间信度及每例RCC敏感度与MRI扫描相当。
研究设计与样本
- 前瞻性研究,纳入24例成人患者(平均年龄52±14岁,14例女性),3个月内接受研究型全身PCCT与腹部MRI检查,并接受手术切除(部分或根治性肾切除术)及组织病理学检查(70个病灶);24例中17例有胚系突变,其余为散发病例;两名放射科医生(R1、R2)评估PCCT与对应MRI,两次阅片间隔3周洗脱期。
诊断标准与关键数值
- R1在PCCT与MRI上检出可疑肿瘤病灶数相似(51 vs 50,P=0.94),R2在PCCT上检出更多可疑病灶(80 vs 56,P=0.12)。
- R1和R2在MRI上将更多病灶判为主要实性(R1:MRI 58/70 vs PCCT 52/70,P<0.001;R2:MRI 60/70 vs PCCT 55/70,P<0.001)。
- R1和R2在PCCT与MRI上检测肿瘤性病灶的表现相似(R1:94% vs 90%,P=0.5;R2:73% vs 79%,P=0.13)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim of this study was to assess the interreader reliability and per-RCC sensitivity of high-resolution photon-counting computed tomography (PCCT) in the detection and characterization of renal masses in comparison to MRI.
MATERIALS AND METHODS: This prospective study included 24 adult patients (mean age, 52 ± 14 years; 14 females) who underwent PCCT (using an investigational whole-body CT scanner) and abdominal MRI within a 3-month time interval and underwent surgical resection (partial or radical nephrectomy) with histopathology (n = 70 lesions). Of the 24 patients, 17 had a germline mutation and the remainder were sporadic cases. Two radiologists (R1 and R2) assessed the PCCT and corresponding MRI studies with a 3-week washout period between reviews. Readers recorded the number of lesions in each patient and graded each targeted lesion's characteristic features, dimensions, and location. Data were analyzed using a 2-sample t test, Fisher exact test, and weighted kappa.
RESULTS: In patients with von Hippel-Lindau mutation, R1 identified a similar number of lesions suspicious for neoplasm on both modalities (51 vs 50, P = 0.94), whereas R2 identified more suspicious lesions on PCCT scans as compared with MRI studies (80 vs 56, P = 0.12). R1 and R2 characterized more lesions as predominantly solid in MRIs (R1: 58/70 in MRI vs 52/70 in PCCT, P < 0.001; R2: 60/70 in MRI vs 55/70 in PCCT, P < 0.001). R1 and R2 performed similarly in detecting neoplastic lesions on PCCT and MRI studies (R1: 94% vs 90%, P = 0.5; R2: 73% vs 79%, P = 0.13).
CONCLUSIONS: The interreader reliability and per-RCC sensitivity of PCCT scans acquired on an investigational whole-body PCCT were comparable to MRI scans in detecting and characterizing renal masses.
CLINICAL RELEVANCE STATEMENT: PCCT scans have comparable performance to MRI studies while allowing for improved characterization of the internal composition of lesions due to material decomposition analysis. Future generations of this imaging modality may reveal additional advantages of PCCT over MRI.
引用
- Homayounieh F, Gopal N, Firouzabadi FD, et al. A Prospective Study of the Diagnostic Performance of Photon-Counting CT Compared With MRI in the Characterization of Renal Masses. Invest Radiol. 2024. PMID: 38767436. doi:10.1097/RLI.0000000000001087
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。